These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 26167495)
21. Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study. Ardon H; Van Gool S; Lopes IS; Maes W; Sciot R; Wilms G; Demaerel P; Bijttebier P; Claes L; Goffin J; Van Calenbergh F; De Vleeschouwer S J Neurooncol; 2010 Sep; 99(2):261-72. PubMed ID: 20146084 [TBL] [Abstract][Full Text] [Related]
22. Advances in Immunotherapy for Glioblastoma Multiforme. Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344 [TBL] [Abstract][Full Text] [Related]
23. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells. Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of immunomodulation in human glioblastoma. Avril T; Vauleon E; Tanguy-Royer S; Mosser J; Quillien V Immunotherapy; 2011 Apr; 3(4 Suppl):42-4. PubMed ID: 21524170 [TBL] [Abstract][Full Text] [Related]
25. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY Front Immunol; 2018; 9():727. PubMed ID: 29910795 [TBL] [Abstract][Full Text] [Related]
27. Cellular-based immunotherapies for patients with glioblastoma multiforme. Xu X; Stockhammer F; Schmitt M Clin Dev Immunol; 2012; 2012():764213. PubMed ID: 22474481 [TBL] [Abstract][Full Text] [Related]
28. Active dendritic cell immunotherapy for glioblastoma: Current status and challenges. Polyzoidis S; Tuazon J; Brazil L; Beaney R; Al-Sarraj ST; Doey L; Logan J; Hurwitz V; Jarosz J; Bhangoo R; Gullan R; Mijovic A; Richardson M; Farzaneh F; Ashkan K Br J Neurosurg; 2015 Apr; 29(2):197-205. PubMed ID: 25541743 [TBL] [Abstract][Full Text] [Related]
29. Peptide vaccines for the treatment of glioblastoma. Swartz AM; Batich KA; Fecci PE; Sampson JH J Neurooncol; 2015 Jul; 123(3):433-40. PubMed ID: 25491947 [TBL] [Abstract][Full Text] [Related]
30. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy. Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290 [TBL] [Abstract][Full Text] [Related]
31. Dendritic cells cross-talk with tumour antigen-specific CD8 Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488 [TBL] [Abstract][Full Text] [Related]
32. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review. Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676 [TBL] [Abstract][Full Text] [Related]
33. Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme. Almeida ND; Klein AL; Hogan EA; Terhaar SJ; Kedda J; Uppal P; Sack K; Keidar M; Sherman JH World Neurosurg; 2019 Oct; 130():369-376. PubMed ID: 31284051 [TBL] [Abstract][Full Text] [Related]
34. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470 [TBL] [Abstract][Full Text] [Related]